IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SESHAGIRI R DANDAMUDI

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1174503221
CMS profile
188772
Location
BATTLE CREEK, MI

General Payments · PY2018–2024

$6,204.85

  • Reported across 385 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,167.96

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Allergy MI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,154.20 51
Education $13.76 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $262.31 10
Acerta Pharma LLC $206.10 11
NOVARTIS PHARMACEUTICALS CORPORATION $189.51 11
Blueprint Medicines Corporation $180.13 4
Regeneron Healthcare Solutions, Inc. $70.48 3
Genentech USA, Inc. $47.72 2
Alkermes, Inc. $44.38 2
OptiNose US, Inc. $40.24 2
Takeda Pharmaceuticals U.S.A., Inc. $31.65 2
Neurocrine BioSciences, Inc. $29.36 1
GlaxoSmithKline, LLC. $29.25 2
ABBVIE INC. $22.01 1
ITI, Inc. $14.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $450.75 36
PY2019 $799.02 48
PY2020 $766.01 56
PY2021 $1,153.68 82
PY2022 $904.08 58
PY2023 $963.35 53
PY2024 $1,167.96 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.01 09/04/2024 Food and Beverage Undisputed 01/23/2026 1103597532 CMS
Alkermes, Inc. $20.41 04/15/2024 Food and Beverage Undisputed 01/23/2026 1120486747 CMS
Alkermes, Inc. $23.97 09/18/2024 Food and Beverage Undisputed 01/23/2026 1120486749 CMS
AstraZeneca Pharmaceuticals LP $16.74 02/12/2024 Food and Beverage Undisputed 01/23/2026 1104201775 CMS
AstraZeneca Pharmaceuticals LP $19.54 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104771792 CMS
AstraZeneca Pharmaceuticals LP $19.66 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105551666 CMS
AstraZeneca Pharmaceuticals LP $19.46 05/06/2024 Food and Beverage Undisputed 01/23/2026 1105796574 CMS
AstraZeneca Pharmaceuticals LP $16.52 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105250144 CMS
AstraZeneca Pharmaceuticals LP $13.97 07/15/2024 Food and Beverage Undisputed 01/23/2026 1104407877 CMS
AstraZeneca Pharmaceuticals LP $21.18 07/23/2024 Food and Beverage Undisputed 01/23/2026 1105822349 CMS
AstraZeneca Pharmaceuticals LP $22.92 09/16/2024 Food and Beverage Undisputed 01/23/2026 1105798184 CMS
AstraZeneca Pharmaceuticals LP $13.72 10/01/2024 Food and Beverage Undisputed 01/23/2026 1104234065 CMS
AstraZeneca Pharmaceuticals LP $17.12 11/19/2024 Food and Beverage Undisputed 01/23/2026 1105617517 CMS
AstraZeneca Pharmaceuticals LP $25.27 12/02/2024 Food and Beverage Undisputed 01/23/2026 1104362227 CMS
Blueprint Medicines Corporation $90.49 02/24/2024 Food and Beverage Undisputed 01/23/2026 1147454645 CMS
Blueprint Medicines Corporation $30.42 04/22/2024 Food and Beverage Undisputed 01/23/2026 1147454583 CMS
Blueprint Medicines Corporation $25.45 05/13/2024 Food and Beverage Undisputed 01/23/2026 1147454589 CMS
Blueprint Medicines Corporation $33.77 08/12/2024 Food and Beverage Undisputed 01/23/2026 1147454617 CMS
Genentech USA, Inc. $23.91 07/08/2024 Food and Beverage Undisputed 01/23/2026 1133110097 CMS
Genentech USA, Inc. $23.81 09/30/2024 Food and Beverage Undisputed 01/23/2026 1133110101 CMS
GENZYME CORPORATION $31.14 02/20/2024 Food and Beverage Undisputed 01/23/2026 1139596047 CMS
GENZYME CORPORATION $36.03 04/09/2024 Food and Beverage Undisputed 01/23/2026 1139596055 CMS
GENZYME CORPORATION $34.36 05/14/2024 Food and Beverage Undisputed 01/23/2026 1139596063 CMS
GENZYME CORPORATION $41.23 06/18/2024 Food and Beverage Undisputed 01/23/2026 1139596073 CMS
GENZYME CORPORATION $34.36 07/16/2024 Food and Beverage Undisputed 01/23/2026 1139596077 CMS
GENZYME CORPORATION $26.50 09/10/2024 Food and Beverage Undisputed 01/23/2026 1139596111 CMS
GENZYME CORPORATION $6.73 10/08/2024 Food and Beverage Undisputed 01/23/2026 1139596125 CMS
GENZYME CORPORATION $10.50 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139596143 CMS
GENZYME CORPORATION $23.76 11/12/2024 Food and Beverage Undisputed 01/23/2026 1139596149 CMS
GENZYME CORPORATION $17.70 12/10/2024 Food and Beverage Undisputed 01/23/2026 1139596161 CMS
GlaxoSmithKline, LLC. $14.02 06/10/2024 Food and Beverage Undisputed 01/23/2026 1116700363 CMS
GlaxoSmithKline, LLC. $15.23 11/26/2024 Food and Beverage Undisputed 01/23/2026 1115960263 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.82 04/29/2024 Food and Beverage Undisputed 01/23/2026 1143213478 CMS
Neurocrine Biosciences, Inc. $29.36 04/08/2024 Food and Beverage Undisputed 01/23/2026 1150827382 CMS
Novartis Pharmaceuticals Corporation $20.87 01/05/2024 Food and Beverage Undisputed 01/23/2026 1086843197 CMS
Novartis Pharmaceuticals Corporation $17.23 01/18/2024 Food and Beverage Undisputed 01/23/2026 1086843201 CMS
Novartis Pharmaceuticals Corporation $14.89 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086843203 CMS
Novartis Pharmaceuticals Corporation $22.37 05/01/2024 Food and Beverage Undisputed 01/23/2026 1086843207 CMS
Novartis Pharmaceuticals Corporation $17.95 06/10/2024 Food and Beverage Undisputed 01/23/2026 1086843217 CMS
Novartis Pharmaceuticals Corporation $18.31 07/09/2024 Food and Beverage Undisputed 01/23/2026 1086843219 CMS
Novartis Pharmaceuticals Corporation $18.20 07/22/2024 Food and Beverage Undisputed 01/23/2026 1086843221 CMS
Novartis Pharmaceuticals Corporation $18.97 08/02/2024 Food and Beverage Undisputed 01/23/2026 1086843223 CMS
Novartis Pharmaceuticals Corporation $12.20 08/14/2024 Food and Beverage Undisputed 01/23/2026 1086843229 CMS
Novartis Pharmaceuticals Corporation $13.26 08/27/2024 Food and Beverage Undisputed 01/23/2026 1086843231 CMS
Novartis Pharmaceuticals Corporation $15.26 09/20/2024 Food and Beverage Undisputed 01/23/2026 1086843233 CMS
Optinose US, Inc. $20.44 02/20/2024 Food and Beverage Undisputed 01/23/2026 1142188636 CMS
Optinose US, Inc. $19.80 04/22/2024 Food and Beverage Undisputed 01/23/2026 1142188682 CMS
Regeneron Healthcare Solutions, Inc. $21.66 02/26/2024 Food and Beverage Undisputed 01/23/2026 1114032728 CMS
Regeneron Healthcare Solutions, Inc. $31.27 03/12/2024 Food and Beverage Undisputed 01/23/2026 1114032730 CMS
Regeneron Healthcare Solutions, Inc. $17.55 04/30/2024 Food and Beverage Undisputed 01/23/2026 1114032732 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.89 09/09/2024 Food and Beverage Undisputed 01/23/2026 1137523632 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.76 09/26/2024 Education Undisputed 01/23/2026 1137523636 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.